Skip to content

Remifentanil and Fentanyl in Dental Surgery (REFEDS)

Remifentanil vs Fentanyl During Day Case Dental Surgery in Persons With Special Needs: a Comparative Study of Their Effect on Stress Response and Postoperative Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02619032
Acronym
REFEDS
Enrollment
46
Registered
2015-12-02
Start date
2005-10-31
Completion date
2009-09-30
Last updated
2015-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

remifentanil, fentanyl, dental surgery

Brief summary

This study was a prospective comparative study. The purpose of this study was to investigate the hypothesis whether remifentanil compared to fentanyl can induce less inflammatory and stress response to the day-case dental surgery in Persons with special needs (PSN). Secondary aims were to investigate comparatively their effect on patients intraoperative hemodynamic response and postoperative analgesia.

Detailed description

The study included 46 adult patients with cognitive impairment who underwent day-case dental surgery under general anesthesia with propofol aiming to keep a BIS-values range between 40-45. Nasal tracheal intubation was performed in all patients while neuromuscular blockade was achieved by rocuronium 0.6 mg/kg iv and repetitive doses of rocuronium of 10 mg iv, if needed. Patients were randomly allocated receive for intraoperative analgesia either fentanyl 50 μg iv bolus (group F, n=23) or continuous infusion of remifentanil 0.5-1 μg/kg/min (group R, n=23). Randomization was performed using using a computer-generated randomization schedule. Intraoperatively, patients in both groups received IV granisetron 3 mg, methylprednisolone 125 mg and clindamycin 600 mg, while atropine 0.02 mg/kg and neostigmine (0.05 mg/kg) was administered to to reverse neuromuscular blockade. Intraoperative monitoring included non-invasive measurement of arterial blood pressure, electrocardiogram, pulse oxymetry, capnography and Bispectral Sedation Index (BIS®). Postoperatively, patients remained under surveillance in the post-anesthesia care unit \[PACU\] for 3 h. Postoperative pain was assessed for the first 12 postoperative hours, at 30 min time-intervals for the first 3 hours, and every 3 hours thereafter by an independent observer, blinded to the study group, using the Wong-Baker faces pain rating scale (0-6). If pain scores were ≥3 a rescue dose of paracetamol 12.5 mg/kg iv was administered. Inflammation markers and stress hormones \[cortisol, Tumor necrosis factor (TNF-a), substance-P, melatonin and β-endorphin\] were measured in each patient before induction of anesthesia, after tracheal intubation and at the end of operation. Statistical Analysis was performed using Kolmogorov-Smirnov test, Student's unpaired t-test or Repeated Measures ANOVA with Holm's post-hoc analysis appropriately. A p value less than 0.05 was considered statistically significant.

Interventions

DRUGRemifentanil

Intraoperative continuous infusion of remifenatanil. Remifentanil infusion was interrupted upon completion of surgical intervention.

DRUGFentanyl

Fentanyl 50 μg iv bolus at the induction of anesthesia and before the start of surgery.

Sponsors

Asklepieion Voulas General Hospital
CollaboratorOTHER_GOV
Attikon Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Patients with cognitive impairment * of category II according to the American Society of Anesthesiology (ASA) classification * scheduled for elective dental surgery with short duration

Exclusion criteria

* Patients of more than category II of American Society of Anesthesiology (ASA) classification * Prolonged duration of surgery (\>1 hour)

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline plasma β-endorphin values at 1 hourAt 1 hour after the induction of anesthesia and surgeryβ-endorphin was measured with Elisa immunoenzyme assay as ng/ml
Change from baseline plasma tumor necrosis factor-α (TNF-α) values at 1 hourAt 1 hour after the induction of anesthesia and surgeryTumor necrosis factor-α (TNF-α) measurement was performed with Elisa immunoenzyme assay as pg/ml
Change from baseline plasma substance-P values at 1 hourAt 1 hour after the induction of anesthesia and surgerySubstance-P measurement was performed with Elisa immunoenzyme assay as ng/ml
Change from baseline plasma melatonin values at 1 hourAt 1 hour after the induction of anesthesia and surgeryMelatonin measurement was performed with Elisa immunoenzyme assay as pg/ml
Change from baseline plasma cortisol values at 1 hourAt 1 hour after the induction of anesthesia and surgeryPlasma cortisol values were measured with an ELISA kit as mg/dl

Secondary

MeasureTime frameDescription
Differences in intraoperative heart rate values (bmp) between the two study groups1 hourMeasurements before the induction of anesthesia (baseline values) and at 60 min (1 hour) after the induction of anesthesia
Differences in postoperative pain scores scores between the two study groupsUp to 12 postoperative hoursPain was assessed using the Wong-Baker faces pain rating scale (0-6) at 12 postoperative hours
Differences in intraoperative systolic arterial blood pressure values (mm Hg) between the two study groups1 hourMeasurements before the induction of anesthesia (baseline values) and at and 60 min (1 hour) after the induction of anesthesia

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026